BCL2 and cancer: A recent study showed that knockdown of NCAPG induced apoptosis, reduced cancer cell survival, and suppressed the epithelial–mesenchymal transition (EMT) in cancer cells via upregulation of Bax, cleaved caspase‐3, and E‐cadherin and downregulation of cyclin A1, CDK2, Bcl‐2, N‐cadherin, and HOXB9 in hepatocellular carcinoma 55.